In addition, while earlier reports detected elevated MSX2 expression in a variety of carcinoma cell lines, more recent studies demonstrated that MSX2 promotes EMT through activation of Wnt signaling in cancer cells [10, 15, 16, 22]. This evidence concerns the gene MSX2 and carcinoma.